A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin
- Status
- UNKNOWN
- Phase
- N/A
Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1
- Status
- COMPLETED
- Phase
- PHASE3
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
- Status
- RECRUITING
- Phase
- PHASE2
A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
- Status
- UNKNOWN
- Phase
- NA
Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Capecitabine in Metastatic Breast and GI Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
- Status
- UNKNOWN
- Phase
- PHASE2
Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2